Yahoo! Finance Search - Finance Home - Yahoo! - Help

Saturday, November 21 2009 9:28pm ET - U.S. Markets Closed.
Industry Center - Biotechnology
Industry Center > Biotechnology > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Biotechnology News
View: Latest News | Top Stories
Friday, Nov 20, 2009
·Expiration Trade Behind Osiris Activity
at Seeking Alpha - Fri 6:26 pm ET
·[external] Dendreon says FDA will disclose Provenge’s fate by May 1
at bizjournals.com - Fri 5:05 pm ET
·[external] Biotech Stocks: Inovio, Merck gain; Novavax falls
at MarketWatch - Fri 4:26 pm ET
·Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal
PR Newswire - Fri 3:40 pm ET
·May Day For Dendreon
at CNBC - Fri 2:51 pm ET
·Dendreon's Provenge gets FDA review date
AP - Fri 10:54 am ET
·Antigenics pulls European Oncophage application
AP - Fri 10:52 am ET
·[external] Biotech Stocks: Inovio soars, Novavax falls in early action
at MarketWatch - Fri 10:43 am ET
·Novavax plans offering of 6.8M shares; stock falls
AP - Fri 10:36 am ET
·BioCryst prices stock offering at $9.75 per share
AP - Fri 10:17 am ET
·Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research Analyst
Wall Street Transcript - Fri 9:49 am ET
·Novavax Prices Public Offering of Common Stock
PR Newswire - Fri 9:35 am ET
·Dendreon Receives FDA Acknowledgement of Complete Response
PR Newswire - Fri 8:30 am ET
·European CHMP Formally Adopts Negative Opinion on Oncophage®
Business Wire - Fri 8:25 am ET
·Genasense® Given as High-Dose IV Infusion with Chemotherapy Shows Promising Activity in Advanced Melanoma
Business Wire - Fri 8:04 am ET
·Ligand Presents New Preclinical Data on its Lead SARM Molecule LGD-4033 at the Gerontological Society of America Annual Meeting
Business Wire - Fri 8:00 am ET
·Novavax Announces Public Offering of Common Stock
PR Newswire - Fri 7:45 am ET
·FDA Extends NDA Review for Exalgo Extended-Release Tablets
Business Wire - Fri 7:30 am ET
·A Possible New Indication for Progenix's Relistor Could Revive Its Fortunes
at Seeking Alpha - Fri 6:07 am ET
·[external] Biotech Stock Mailbag: FDA Playbook
at TheStreet.com - Fri 6:01 am ET
More Latest News...
Sponsor Results
Top Biotechnology Stocks
3 Pharmaceutical Companies To Invest In Now! Get The Free Report.
www.Fool.com
Trade Stocks? Try Currency Trading
Trade in a highly trending market 24-hrs a day, 5.5 days a week. GFT.
www.GFTforex.com
Pharma News and Events
Free Information Articles & Events Biotechnology Article Archive.
www.Bio-ITworld.com
(What's This?)
  

RSS Feeds

Add headlines to your
personalized My Yahoo! Page
( About My Yahoo! and RSS )

Biotechnology Headlines
More Finance RSS Feeds

Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2009 Morningstar, Inc. All Rights Reserved. Company information © 2009 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2009, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo! nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo! site, a user agrees not to redistribute the information found therein.
Questions or Comments?